www.fdanews.com/articles/88239-eurocor-gmbh-receives-ce-mark-approval-for-taxcor-i
EUROCOR GMBH RECEIVES CE MARK APPROVAL FOR TAXCOR I
July 10, 2006
Eurocor Gmbh an Opto Circuits company has received CE mark approval of its new polymer-free, TAXCOR I.Paclitaxel-eluting coronary stent system. Though polymer-free, this innovative
drug-eluting stent technology eliminates any polymer-related, late adverse effect
potential for the patient, like subacute thrombosis.
My
Iris